publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
effector
cellderiv
enhanc
acut
liver
immunopatholog
highlight
effector
cell
produc
upon
hepatocellular
antigen
encount
enhanc
respons
inhibit
antigeninduc
effector
cell
apoptosi
cellderiv
support
liver
immunopatholog
mostli
regard
immunosuppress
cytokin
show
hbvspecif
cell
produc
upon
antigen
recognit
cytokin
enhanc
cell
surviv
paradox
promot
rather
suppress
liver
diseas
background
aim
besid
secret
proinflammatori
cytokin
chemokin
effector
molecul
effector
cell
aris
upon
acut
infect
certain
virus
shown
produc
regulatori
cytokin
interleukin
il
therefor
contain
immunopatholog
whether
occur
acut
hepat
b
viru
hbv
infect
role
might
play
liver
diseas
current
unknown
method
mous
model
acut
hbv
pathogenesi
well
chimpanze
patient
acut
infect
hbv
use
analys
role
cellderiv
liver
immunopatholog
result
mous
hbvspecif
effector
cell
produc
signific
amount
upon
vivo
antigen
encount
corrobor
longitudin
data
chimpanze
acut
infect
hbv
serum
readili
detect
correl
intrahepat
cell
infiltr
liver
diseas
sever
unexpectedli
mous
human
cellderiv
found
act
autocrineparacrin
fashion
enhanc
respons
thu
prevent
antigeninduc
hbvspecif
effector
cell
apoptosi
accordingli
use
mous
model
hbv
pathogenesi
reveal
produc
effector
cell
promot
intrahepat
surviv
thu
support
rather
suppress
liver
immunopatholog
conclus
effector
cellderiv
enhanc
acut
liver
immunopatholog
altogeth
result
extend
understand
celland
tissuespecif
role
exert
immun
regul
lay
summari
mostli
regard
immunosuppress
cytokin
show
hbvspecif
cell
produc
upon
antigen
recognit
cytokin
enhanc
cell
surviv
paradox
promot
rather
suppress
liver
diseas
wide
recogn
hepat
b
viru
hbv
replic
noncytopath
hepatocyt
clinic
complic
relat
infect
reflect
adapt
immun
respons
particularli
virusspecif
effector
cell
respons
inde
kill
infect
cell
secret
antivir
cytokin
effector
cell
e
reach
infect
site
major
contributor
viral
clearanc
well
tissu
immunopatholog
paradox
acut
viral
infect
eg
caus
influenza
viru
respiratori
syncyti
viru
coronaviru
vaccinia
viru
e
shown
produc
regulatori
cytokin
interleukin
il
addit
proinflammatori
cytokin
chemokin
effector
molecul
e
deriv
gener
thought
limit
tissu
damag
howev
net
effect
induc
cytokin
might
depend
pathophysiolog
context
whether
hbvspecif
e
produc
upon
hepatocellular
antigen
ag
recognit
role
cytokin
play
liver
immunopatholog
current
unknown
show
serum
readili
detect
acut
hbvinfect
adult
chimpanze
manner
coincid
intrahepat
cell
infiltr
use
mous
model
acut
hbv
pathogenesi
confirm
inde
produc
hbvspecif
e
upon
hepatocellular
ag
recognit
vivo
surpris
blockad
amelior
rather
worsen
liver
diseas
ex
vivo
analys
hbvspecif
e
isol
liver
hbv
replicationcompet
transgen
mice
blood
acut
infect
patient
reveal
act
autocrineparacrin
fashion
increas
respons
rescu
e
aginduc
apoptosi
chimpanze
chimpanze
alreadi
describ
anim
handl
accord
human
use
care
guidelin
specifi
anim
research
committe
nation
institut
health
scripp
research
institut
bioqual
laboratori
chimpanze
individu
hous
bioqual
laboratori
rockvil
md
american
associ
accredit
laboratori
anim
care
internationalaccredit
institut
contract
nation
institut
allergi
infecti
diseas
chimpanze
inocul
genom
equival
hbv
obtain
hbvposit
serum
chimpanze
previous
inocul
monoclon
hbv
isol
genotyp
ayw
subtyp
genbank
access
contain
hbv
transgen
mous
serum
describ
blood
obtain
venipunctur
analyz
serum
see
mice
inbr
balbc
mice
purchas
charl
river
mice
j
purchas
jackson
laboratori
hbv
replicationcompet
transgen
mice
lineag
inbr
b
express
hbv
antigen
replic
hbv
liver
high
level
without
evid
cytopatholog
previous
describ
indic
experi
mice
use
x
balbc
bxd
hybrid
hbv
nucleocapsid
cor
specif
refer
cell
cell
receptor
tcr
transgen
mice
lineag
inbr
splenic
cell
recogn
k
b
restrict
epitop
locat
residu
hbv
core
protein
mglkfrql
previous
describ
envelop
tcr
transgen
mice
lineag
inbr
balb
c
splenic
cell
recogn
l
restrict
epitop
locat
residu
hbsag
ipqsldswwtsl
previous
describ
indic
experi
lineag
lineag
cross
mice
mice
hous
specif
pathogenfre
condit
use
week
age
experi
mice
match
age
sex
anim
serum
hbeag
level
experiment
manipul
experiment
anim
procedur
approv
institut
anim
committe
san
raffael
scientif
institut
five
patient
acut
selflimit
hbv
infect
enrol
unit
infecti
diseas
hepatolog
parma
itali
patient
clinic
biochem
virolog
evid
acut
hbv
infect
aminotransferas
level
least
time
upper
normal
limit
detect
hbsag
igm
antihbcag
ab
serum
patient
neg
antihcv
antidelta
viru
ab
marker
viral
autoimmun
hepat
cell
respons
test
one
month
time
acut
ill
studi
approv
ethic
committe
azienda
ospedalierouniversitaria
parma
subject
gave
written
inform
consent
vitro
gener
e
perform
describ
briefli
splenocyt
tcr
transgen
mice
incub
lgml
k
b
mglkfrql
l
ipqsldswwtsl
peptid
primm
respect
h
wash
cultur
complet
rpmi
fb
mm
lglutamin
lm
hepe
mm
non
essenti
amino
acid
lm
penicillin
plu
streptomycin
two
day
later
cell
cultur
fresh
medium
supplement
supernat
media
supplement
cytokin
replac
everi
day
day
cultur
cell
test
express
ifnc
granzym
b
fac
prior
subsequ
use
describ
cell
cell
type
inject
intraven
recipi
anim
total
rna
isol
cultur
cell
frozen
liver
left
lobe
reliaprep
rna
miniprep
system
promega
follow
manufactur
instruct
quantit
rtpcr
lg
total
rna
revers
transcrib
prior
qpcr
analysi
mous
ifng
taqman
probe
appli
biosystem
abi
fast
realtim
pcr
system
appli
biosystem
experi
perform
triplic
normal
refer
gene
gapdh
enzymelink
immunosorb
assay
ifnc
mous
sera
cell
supernat
measur
elisa
biolegend
r
respect
accord
manufactur
instruct
hbeag
mous
sera
measur
elisa
diapro
follow
manufactur
instruct
chimpanze
sera
measur
use
human
elisa
r
system
accord
manufactur
instruct
extent
hepatocellular
injuri
monitor
measur
serum
alanin
aminotransferas
alt
activ
multipl
time
point
treatment
previous
describ
vivo
antibodi
treatment
primari
hepatocyt
isol
wildtyp
hbv
replicationcompet
transgen
mice
inbr
exactli
describ
hepatocyt
puriti
assess
flow
cytometrybas
paramet
size
viabil
assess
light
microscopybas
morpholog
trypan
blue
dye
exclus
routin
greater
respect
hepatocyt
cellsml
incub
ratio
e
h
presenc
lgml
brefeldin
bfa
sigma
prior
intracellular
ifnc
stain
singlecel
suspens
liver
gener
describ
analysi
ex
vivo
intracellular
cytokin
product
cell
suspens
liver
obtain
describ
except
lgml
bfa
sigma
includ
digest
buffer
flow
cytometri
stain
surfaceexpress
intracellular
molecul
perform
describ
antibodi
ab
use
includ
pband
peconjug
alexa
fluor
percp
alexa
fluor
alexa
fluor
antiifnc
peand
pbconjug
apcconjug
annexin
v
bd
pharmingen
ab
purchas
biolegend
unless
otherwis
indic
phosphoryl
analysi
cell
fix
paraformaldehyd
permeabil
absolut
methanol
stain
ebiosci
flow
cytometri
analys
perform
fac
buffer
contain
pb
mm
edta
fb
fac
canto
bd
pharmingen
analyz
flowjo
softwar
treestar
haemotoxylin
eosin
stain
liver
perfus
pb
harvest
znformalin
transfer
ethanol
h
later
tissu
process
embed
paraffin
stain
previous
describ
brightfield
imag
acquir
aperio
scanscop
system
microscop
imagescop
program
leica
biosystem
follow
manufactur
instruct
extent
hepatocellular
injuri
monitor
histopatholog
quantit
morphometr
analys
describ
number
injur
hepatocyt
identifi
either
apoptot
necrot
base
standard
cytopatholog
criteria
intrahepat
inflammatori
cell
mononuclear
polymorphonuclear
count
least
high
power
field
liver
tissu
correspond
mm
result
express
number
cell
per
mm
vitro
cell
cultur
assay
murin
e
test
express
product
ifnc
e
cell
incub
complet
rpmi
media
lgml
roch
cellsml
h
presenc
absenc
peptid
assess
effect
aginduc
apoptosi
e
cell
ml
incub
h
lgml
ab
bioxcel
ngml
recombin
biolegend
left
untreat
prior
addit
peptid
mgml
human
mgml
assess
cell
viabil
cell
harvest
h
later
stain
annexin
v
describ
assess
express
cell
harvest
h
peptid
stimul
phosphoryl
e
cultur
overnight
serumfre
rpmi
complet
medium
gibco
life
technolog
prior
treat
describ
cell
harvest
min
peptid
stimul
measur
effect
aginduc
apoptosi
peripher
blood
mononuclear
cell
pbmc
five
patient
acut
selflimit
hepat
b
concentr
ml
incub
h
lgml
ab
bd
pharmingen
ngml
recombin
human
biolegend
left
untreat
prior
addit
core
peptid
lgml
human
iuml
h
incub
cell
extens
wash
stain
core
dextram
mous
ab
min
dark
stain
annexin
v
bd
pharmingen
accord
annexin
v
stain
protocol
bd
pharmingen
cell
acquir
immedi
facscanto
ii
multicolor
flow
cytomet
analyz
diva
softwar
bd
bioscienc
immunocytometri
system
ca
usa
total
dna
isol
frozen
liver
left
lobe
southern
blot
analysi
previous
describ
result
express
mean
sem
statist
analys
perform
prism
graphpad
softwar
mean
two
group
compar
twotail
test
mean
among
three
group
compar
oneway
twoway
analysi
varianc
anova
bonferroni
posthoc
test
data
analyz
use
fisher
least
signific
differ
lsd
test
first
assess
whether
produc
upon
acut
hbv
infect
longitudin
analyz
sera
chimpanze
inocul
monoclon
hbv
inoculum
ge
hbv
dna
describ
serum
detect
cell
accumul
liver
appear
coincid
onset
necroinflammatori
liver
diseas
fig
suggest
cytokin
might
produc
virusspecif
e
upon
hepatocellular
ag
recognit
test
hypothesi
assess
role
liver
immunopatholog
employ
wellestablish
model
acut
hbv
pathogenesi
ie
adopt
transfer
hbvspecif
e
hbv
replicationcompet
transgen
mice
cell
hbv
nucleocapsid
cor
specif
tcr
transgen
mice
refer
cell
differenti
vitro
bona
fide
e
upon
intraven
inject
e
hbv
replicationcompet
transgen
mice
hepat
mrna
express
gene
increas
sharpli
reach
peak
level
h
cell
transfer
mirror
kinet
prototyp
e
deriv
proinflammatori
antivir
cytokin
gene
ifng
fig
accordingli
also
detect
serum
mice
h
cell
transfer
echo
ifnc
kinet
fig
consist
hypothesi
produc
e
upon
hepatocellular
antigen
recognit
found
e
cell
stimul
h
vitro
cognat
peptid
produc
cytokin
fig
fig
final
unambigu
identifi
cellular
sourc
detect
liver
hbv
replicationcompet
transgen
mice
upon
adopt
transfer
e
genet
delet
gene
hbv
replicationcompet
recipi
mice
e
use
approach
could
demonstr
transfer
e
cell
uniqu
sourc
experiment
set
express
detect
transfer
cell
regardless
recipi
genotyp
fig
gain
insight
role
e
deriv
express
liver
immunopatholog
select
block
receptor
signal
inject
hbv
replicationcompet
transgen
mice
ab
h
prior
e
transfer
surpris
found
blockad
decreas
rather
increas
liver
damag
peak
diseas
fig
note
ab
inject
affect
total
number
circul
e
cell
data
shown
indic
treatment
deplet
transfer
cell
also
ab
treatment
significantli
reduc
liver
diseas
hbv
envelopespecif
tcr
transgen
polyclon
e
inject
hbv
replicationcompet
transgen
mice
instead
e
data
shown
moreov
consist
produc
exclus
transfer
e
model
delet
gene
hbv
replicationcompet
recipi
mice
alter
ag
present
capac
hepatocyt
fig
affect
sever
liver
diseas
induc
e
transfer
fig
explor
mechan
underli
increas
liver
immunopatholog
quantifi
number
function
viabil
intrahepat
e
h
adopt
transfer
hbv
replicationcompet
transgen
mice
subject
ab
treatment
blockad
significantli
decreas
number
total
ifnc
intrahepat
e
cell
recov
h
inject
fig
next
address
reflect
increas
cell
death
inde
percentag
intrahepat
e
underw
apoptosi
h
transfer
significantli
increas
blockad
fig
fig
reflect
lower
diseas
sever
fig
g
although
number
intrahepat
e
reduc
upon
blockad
cell
probabl
produc
enough
ifnc
abolish
viral
replic
fig
explor
e
deriv
directli
decreas
aginduc
apoptosi
expos
purifi
e
ag
presenc
absenc
blockad
exogen
shown
fig
ag
exposur
h
trigger
e
apoptosi
notabl
blockad
increas
percentag
e
becam
apoptot
wherea
addit
exogen
recombin
decreas
e
apoptosi
fig
fig
next
set
determin
mechan
wherebi
prevent
e
die
sinc
propos
enhanc
growth
activ
cell
presenc
reason
e
deriv
might
increas
respons
instanc
modul
receptor
express
inde
aginduc
upregul
e
lower
upon
blockad
wherea
addit
exogen
recombin
increas
upregul
fig
fig
accordingli
block
signal
decreas
capac
e
respond
assess
phosphoryl
treatment
increas
sensit
fig
fig
final
explor
whether
capac
e
deriv
act
autocrineparacrin
fashion
rescu
e
agtrigg
apoptosi
restrict
murin
e
extend
hbvspecif
e
isol
acut
infect
patient
end
pbmc
patient
acut
hepat
b
hbvspecif
cell
specif
visual
hbvspecif
dextram
fig
stimul
cognat
peptid
presenc
absenc
ab
exogen
result
mirror
obtain
murin
e
blockad
increas
aginduc
apoptosi
wherea
addit
recombin
partial
rescu
e
cell
death
fig
conclus
result
indic
e
deriv
act
autocrineparacrin
fashion
increas
respons
rescu
e
aginduc
apoptosi
although
net
contribut
play
natur
hbv
infect
cytokin
may
produc
addit
cell
type
remain
determin
result
describ
herein
suggest
may
promot
rather
suppress
liver
immunopatholog
medium
white
lgml
light
blue
ngml
dark
blue
h
peptid
lgml
ad
ctrl
percentag
annexin
v
apoptot
cell
determin
core
dextram
cell
h
later
result
repres
independ
experi
result
express
mean
sem
p
p
p
mean
two
group
compar
twotail
test
mean
among
three
group
compar
oneway
twoway
analysi
varianc
bonferroni
posthoc
test
data
fig
analyz
use
fisher
least
signific
differ
lsd
test
